Back to Browse Journals » Pragmatic and Observational Research » Volume 1

Biological correlates of migraine and cluster headaches: an overview of their potential use in diagnosis and treatment

Authors Aron D Mosnaim, Javier Puente, Marion E Wolf

Published Date December 2010 Volume 2010:1 Pages 25—32

DOI http://dx.doi.org/10.2147/POR.S13363

Published 6 December 2010

Aron D Mosnaim1, Javier Puente1,2, Marion E Wolf3
1Department of Cellular and Molecular Pharmacology, Rosalind Franklin University, Chicago Medical School, Chicago, IL, USA; 2Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile; 3International Neuropsychiatry Consultants, Highland Park, IL, USA

Abstract: Current diagnostic criteria for headaches are based on the International Classification for Headache Disorders, second edition, which is largely built on data obtained from clinical examinations and patients' medical histories. Despite decades of vigorous basic and clinical research, we still lack reliable clinical laboratory diagnostic markers for headaches, which clearly obstructs the physician's ability to optimize and follow the patient's response to treatment protocols as well as holds back the discovery and implementation of new therapeutic modalities. In this paper, we review and discuss current efforts to identify and characterize biochemical and immunological changes in biological fluids and tissue that may be specifically associated with the etiology and/or pathophysiology of migraine and cluster headaches; we also discuss some of the recent genetic findings and ion channel modulation studies that may help to distinguish among various headache populations.

Keywords: biochemical, immunological, genetic alterations, pain, enkephalin degradation kinetics, enkephalin aminopeptidase

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Behavioral activation for dementia caregivers: scheduling pleasant events and enhancing communications

Au A, Gallagher-Thompson D, Wong MK, Leung J, Chan WC, Chan CC, Lu HJ, Lai MK, Chan K

Clinical Interventions in Aging 2015, 10:611-619

Published Date: 26 March 2015

Changes in sebum levels and the development of acneiform rash in patients with non–small cell lung cancer after treatment with EGFR inhibitors

Nakahara T, Moroi Y, Takayama K, Itoh E, Kido-Nakahara M, Nakanishi Y, Furue M

OncoTargets and Therapy 2015, 8:259-263

Published Date: 28 January 2015

Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines

Lam DC, Luo SY, Deng W, Kwan JS, Rodriguez-Canales J, Cheung AL, Cheng GH, Lin CH, Wistuba II, Sham PC, Wan TS, Tsao SW

OncoTargets and Therapy 2015, 8:195-209

Published Date: 16 January 2015

An extract of the medicinal plant Artemisia annua modulates production of inflammatory markers in activated neutrophils

Hunt S, Yoshida M, Davis CEJ, Greenhill NS, Davis PF

Journal of Inflammation Research 2015, 8:9-14

Published Date: 14 January 2015